These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 11044365

  • 1. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL.
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [Abstract] [Full Text] [Related]

  • 2. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]

  • 3. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.
    Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971
    [Abstract] [Full Text] [Related]

  • 4. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
    Concin N, Stimpfl M, Zeillinger C, Wolff U, Hefler L, Sedlak J, Leodolter S, Zeillinger R.
    Int J Oncol; 2003 Jan 01; 22(1):51-7. PubMed ID: 12469184
    [Abstract] [Full Text] [Related]

  • 5. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.
    Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA.
    Oncogene; 1995 Aug 03; 11(3):493-504. PubMed ID: 7630633
    [Abstract] [Full Text] [Related]

  • 6. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D, Siré EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M, Broggini M.
    Cancer Res; 1997 Mar 01; 57(5):870-4. PubMed ID: 9041188
    [Abstract] [Full Text] [Related]

  • 7. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP, Gazzeri S, Riva C, Reyt E, Brambilla C, Brambilla E.
    Anticancer Res; 1998 Mar 01; 18(6B):4741-9. PubMed ID: 9891551
    [Abstract] [Full Text] [Related]

  • 8. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
    Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG.
    Cancer Res; 2002 May 01; 62(9):2644-9. PubMed ID: 11980662
    [Abstract] [Full Text] [Related]

  • 9. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels.
    Zhang GJ, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R, Takenoshita S.
    Clin Cancer Res; 1999 Oct 01; 5(10):2971-7. PubMed ID: 10537367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 01; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents.
    Kawakami K, Tsukuda M, Mizuno H, Nishimura G, Ishii A, Hamajima K.
    Anticancer Res; 1999 Oct 01; 19(5B):3927-32. PubMed ID: 10628333
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells.
    Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R.
    Oncogene; 1999 Apr 08; 18(14):2357-65. PubMed ID: 10327056
    [Abstract] [Full Text] [Related]

  • 15. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T.
    Cancer Res; 2001 Feb 01; 61(3):1029-37. PubMed ID: 11221829
    [Abstract] [Full Text] [Related]

  • 16. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
    Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE.
    Cell Growth Differ; 1995 Nov 01; 6(11):1395-403. PubMed ID: 8562478
    [Abstract] [Full Text] [Related]

  • 17. An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
    Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace AJ.
    Cancer Res; 2000 Nov 01; 60(21):6101-10. PubMed ID: 11085534
    [Abstract] [Full Text] [Related]

  • 18. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells.
    Kang KH, Kim WH, Choi KH.
    Exp Cell Res; 1999 Dec 15; 253(2):403-12. PubMed ID: 10585263
    [Abstract] [Full Text] [Related]

  • 19. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.
    Sugikawa E, Hosoi T, Yazaki N, Gamanuma M, Nakanishi N, Ohashi M.
    Anticancer Res; 1999 Dec 15; 19(4B):3099-108. PubMed ID: 10652599
    [Abstract] [Full Text] [Related]

  • 20. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
    Jiang MC, Yang-Yen HF, Lin JK, Yen JJ.
    Oncogene; 1996 Aug 01; 13(3):609-16. PubMed ID: 8760302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.